Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04222101 · ClinicalTrials.gov registry record · NA

Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy

A NA study, sponsored by Le Bonheur Children's Hospital.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT04222101: Clinical Trial NA study, sponsored by Le Bonheur Children's Hospital.

NCT04222101 is a NA study that was terminated before completion, run by Le Bonheur Children's Hospital. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04222101, a NA study, was terminated before completion, sponsored by Le Bonheur Children's Hospital.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

This study will investigate whether there is an association between insulin resistance and cardiac function in children with dilated or hypertrophic cardiomyopathy. This study will also investigate whether there is an association between FGF21 and cardiac function in children with dilated or hypertrophic cardiomyopathy and whether this is mediated through greater insulin resistance and/or through independent effects.

Primary Outcome

correlate whole body insulin sensitivity index with left ventricular ejection fraction

Interventions

  • DIAGNOSTIC_TEST Oral glucose tolerance test

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2019-10-07
Est. Completion 2021-06-30
Phase NA
Le Bonheur Children's Hospital

14 total trials

Why NCT04222101 stopped before completion

NCT04222101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.

NCT04222101 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04222101 about?

NCT04222101 is a clinical study titled "Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy". This study will investigate whether there is an association between insulin resistance and cardiac function in children with dilated or hypertrophic cardiomyopathy. This study will also investigate whether there is an association between FGF21 and cardiac function in children with dilated or hypertr...

What is the current status of trial NCT04222101?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2019-10-07. Estimated completion is 2021-06-30.

What interventions are being tested in trial NCT04222101?

The interventions under investigation include: Oral glucose tolerance test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04222101?

This trial is sponsored by Le Bonheur Children's Hospital, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04222101's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04222101, the US trial registry maintained by the National Library of Medicine. NCT04222101 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.